| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/24/2002 | US6455050 Human administration comprising a protective, highly-immunogenic, non-immunopotentiating copurified mixture of hn and f glycoproteins of human parainfluenza type 3 prepared by copurification from native piv-3 virus by affinity |
| 09/24/2002 | US6455047 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene |
| 09/24/2002 | CA2404420A1 Selective medium for beauveriolide i substance or beauveriolide iii substance and selective production thereof |
| 09/24/2002 | CA2065325C Cdr grafted anti-cea antibodies and their production |
| 09/24/2002 | CA1341388C Hybrid pesticidal toxins |
| 09/23/2002 | CA2378494A1 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 09/20/2002 | CA2342376A1 A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 09/19/2002 | WO2002072890A1 Improved in vitro synthesis system |
| 09/19/2002 | WO2002072863A2 Methods for large scale protein matching |
| 09/19/2002 | WO2002072861A1 Cd53 cell surface antigen |
| 09/19/2002 | WO2002072847A2 Process for production of polypeptides |
| 09/19/2002 | WO2002072843A1 Novel vectors for animal cells and utilization thereof |
| 09/19/2002 | WO2002072832A2 Therapeutic binding molecules |
| 09/19/2002 | WO2002072831A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072826A2 Neurotrophic factors |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072788A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 09/19/2002 | WO2002072776A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | WO2002072769A2 Human serpin polypeptides |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072628A1 Physiologically active polypeptide and polynucleotide encoding the same |
| 09/19/2002 | WO2002072626A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 09/19/2002 | WO2002072615A1 Method of purifying protein |
| 09/19/2002 | WO2002072607A2 Soluble heterodimeric cytokine receptor |
| 09/19/2002 | WO2002072600A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | WO2002072596A1 Steap-related protein |
| 09/19/2002 | WO2002072036A2 Compositions and methods comprising west nile virus polypeptides |
| 09/19/2002 | WO2002072030A2 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | WO2002072015A2 M cell directed vaccines |
| 09/19/2002 | WO2002072013A2 Method of treating malignancies through induction of blood immune responses |
| 09/19/2002 | WO2002071847A1 Treatment of neurodegenerative diseases and conditions using pari antagonists |
| 09/19/2002 | WO2002040696A3 Methods for large scale protein production in prokaryotes |
| 09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
| 09/19/2002 | WO2002022871A3 Polymorphic bone morphogenetic protein 2 |
| 09/19/2002 | WO2002022631A3 Regulation of human pyroglutamyl peptidase-like enzyme |
| 09/19/2002 | WO2002018553A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | WO2002010382A9 Trp8, trp9 and trp10, markers for cancer |
| 09/19/2002 | WO2002004487A3 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/19/2002 | WO2002002610A3 Secretion and trafficking molecules |
| 09/19/2002 | WO2001072140A3 Biopolymers and production thereof with coupled product recovery |
| 09/19/2002 | WO2001036630A9 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/19/2002 | WO2001007483A9 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 09/19/2002 | WO1997046589A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 09/19/2002 | US20020133849 Nucleotide sequences coding enzymatic polypeptide for use in the foods, adhesives, textiles, fertilizers, medicine, cosmetics and papermaking |
| 09/19/2002 | US20020133847 Plant proteins |
| 09/19/2002 | US20020133845 Barstar gene |
| 09/19/2002 | US20020133001 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/19/2002 | US20020132997 Nucleotide sequences coding enzymatic polypeptide for use as amplification tool in genetic engineering |
| 09/19/2002 | US20020132990 Bioengineered vehicles for targeted nucleic acid delivery |
| 09/19/2002 | US20020132988 Generation preferential antibody; construct peptide library, immunize cells, isolating and purify antisera from cells |
| 09/19/2002 | US20020132981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132979 Monoclonal antibody for use in the diagnosis, prevention and treatment of tumors |
| 09/19/2002 | US20020132775 Human potassium channel 1 and 2 proteins |
| 09/19/2002 | US20020132768 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132767 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132753 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132347 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
| 09/19/2002 | US20020132334 Nucleotide sequences coding preferential polypeptide for use in the treatment of tumors and nervous system disorders |
| 09/19/2002 | US20020132330 Polypeptide for use in the treatment, prevention and diagnosis of inflammation, cell proliferation and apoptosis |
| 09/19/2002 | US20020132306 Premature antihemopliic factor; for use in the treatment of blood disorders |
| 09/19/2002 | US20020132299 Production of proteins by cell culture |
| 09/19/2002 | US20020132297 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 09/19/2002 | US20020132289 Olfactory receptors and their utilizations |
| 09/19/2002 | US20020132287 Generation of protein hydrolysate from soy flour; obtain soy flour, generate slurry, hydrolyze, deactivate enzymes, separate solids, recover protein hydrolysate |
| 09/19/2002 | US20020132269 For use in diagnosis therapy |
| 09/19/2002 | US20020132262 Nucleotide sequences coding tumor suppressor protein for use in the diagnosis and treatment of cancer |
| 09/19/2002 | US20020132253 Nucleotide sequences coding membrane protein for use in diagnosis and treatment of athersclerosis, infections, arthritis, cancer, kidney and nervous system disorders |
| 09/19/2002 | US20020132252 Nucleotide sequences coding membrane protein for use in the diagnosis and treatment of infections, arthritis, nervous system and kidney disorders, cancer and atherosclerosis |
| 09/19/2002 | US20020132248 Generating nonradioactive marker for use in genetic analysis; obtain adjusted adaptor nucleotide sequences, incubate with target sequences, translated and recover protein |
| 09/19/2002 | US20020132240 Nucleotide sequences coding membrane proteins for use in treatment of cancer, infections, cardiavascular, nervous system, skin and kidney disorders |
| 09/19/2002 | US20020132228 Phage antibodies |
| 09/19/2002 | US20020131983 Method for inducing an immunological response in a host by administering to the host at least one antigen and a lipoprotein |
| 09/19/2002 | US20020131968 An Immunoglobulin G (IgG) antibody with binding affinity for the CD3 antigen in which the heavy chain has a variable region framework together with specified complementary determining region (CDR); immunosuppressant, treating cancer |
| 09/19/2002 | US20020131967 Such as melphalan and an anti-interleukin-6 receptor antibody, administering in synergistic amounts |
| 09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | CA2441082A1 Steap-related protein |
| 09/19/2002 | CA2440974A1 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | CA2440618A1 Immunoglobulin superfamily proteins |
| 09/19/2002 | CA2440593A1 Compositions and methods comprising west nile virus polypeptides |
| 09/19/2002 | CA2440531A1 Improved in vitro synthesis system |
| 09/19/2002 | CA2440511A1 Methods for large scale protein matching |
| 09/19/2002 | CA2440433A1 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | CA2439637A1 Human serpin polypeptides |
| 09/19/2002 | CA2438074A1 Process for production of polypeptides |
| 09/19/2002 | CA2437963A1 Therapeutic binding molecules |
| 09/19/2002 | CA2437756A1 Nucleic acid-associated proteins |
| 09/19/2002 | CA2435998A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/19/2002 | CA2434762A1 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/18/2002 | EP1241269A2 Method for detecting REG-like protein and nucleic acids coding therefor |
| 09/18/2002 | EP1241264A1 Monoclonal antibodies to colon cancer antigen |
| 09/18/2002 | EP1241258A2 Stem cell factor |
| 09/18/2002 | EP1241257A1 Novel tachykinin-like polypeptides and use thereof |
| 09/18/2002 | EP1241256A1 Novel gene and use thereof |
| 09/18/2002 | EP1240521A2 Identification of disease markers involving mass-based-separation |
| 09/18/2002 | EP1240519A2 Compositions and methods for detecting treponema pallidum |
| 09/18/2002 | EP1240335A2 Proteases |
| 09/18/2002 | EP1240331A2 i CHLAMYDIA /i ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |